Related Experiment Video

Updated: Feb 23, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

11.2K

BRD4 facilitates DNA damage response and represses CBX5/Heterochromatin protein 1 (HP1)

Georgios Pongas1, Marianne K Kim1, Dong J Min2

  • 1Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Oncotarget
|September 9, 2017
PubMed

Insights

Targeting CHK1 and BRD4 together may treat ovarian cancer. BRD4 suppression enhances CHK1 inhibition by increasing DNA damage response, offering a new therapeutic strategy for high-grade serous ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Ovarian cancer (OC) is a heterogeneous disease with DNA repair defects.
  • High-grade serous ovarian cancer (HGSOC) has limited universally expressed targets.
  • CHK1 is overexpressed in most HGSOC cases.

Purpose of the Study:

  • To investigate the DNA damage response (DDR) to CHK1 inhibition.
  • To enhance the anti-tumor activity of CHK1 inhibition.
  • To explore the role of BRD4 in HGSOC and its interaction with CHK1 inhibition.

Main Methods:

  • Utilized siRNA and the BRD4 inhibitor JQ1 for BRD4 suppression.
  • Administered CHK1 inhibitors to induce DNA damage response.
  • Assessed cytotoxicity and DNA damage markers (γ-H2AX).
  • Analyzed BRD4 amplification and upregulation in HGSOC patient data.

Main Results:

  • BRD4 suppression enhanced the cytotoxicity of CHK1 inhibition.
  • BRD4 was amplified/upregulated in a subset of HGSOC, correlating with survival.
  • BRD4 inhibition increased CBX5 (HP1α) levels.
  • Nuclear localization of CBX5 and γ-H2AX was mutually exclusive upon combined inhibition, suggesting BRD4 represses CBX5 to facilitate DDR.

Conclusions:

  • BRD4 suppression potentiates CHK1 inhibition-induced cytotoxicity in HGSOC.
  • BRD4 plays a role in facilitating DNA damage response by repressing CBX5.
  • Co-inhibition of CHK1 and BRD4 is a promising clinical strategy for HGSOC, particularly in patients with BRD4 overexpression.
Keywords:
BRD4CBX5CHK1DNA repairheterochromatin

More Related Videos

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

14.7K
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.7K

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.2K
Homologous Recombination02:31

Homologous Recombination

6.9K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.4K